This inventor holds 2 USPTO granted patents. Top assignees: Solazyme, Inc., University of Manitoba. Active years: 2014-2016.
Company Filing History:
2 out of 63 
2 out of 211 
Years Active: 2014-2016
Title: Scott Harding: Innovator in Algal Biomass Applications
Introduction
Scott Harding is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of biotechnology, particularly in the treatment of impaired glucose metabolism. With a total of two patents to his name, Harding's work focuses on innovative methods that utilize algal biomass for health benefits.
Latest Patents
Harding's latest patents revolve around the use of microalgal biomass in treating individuals with impaired glucose metabolism. These inventions are aimed at patients suffering from conditions such as impaired fasting glucose, impaired glucose tolerance, or diabetes. The methods involve using algal biomass to reduce blood glucose levels and body fat in subjects, as well as to enhance the abundance of beneficial gut microflora. Notably, the algal biomass used in these methods is derived from cultures grown heterotrophically, ensuring that the algal cells contain at least 15% algal oil by dry weight.
Career Highlights
Throughout his career, Scott Harding has worked with prominent organizations such as Solazyme, Inc. and the University of Manitoba. His experience in these institutions has allowed him to develop and refine his innovative approaches to health and nutrition.
Collaborations
Some of Harding's notable coworkers include David Brinkmann and Anthony G Day. Their collaborative efforts have contributed to the advancement of research in algal biomass applications.
Conclusion
Scott Harding's work exemplifies the intersection of innovation and health, particularly through the use of algal biomass in treating metabolic disorders. His contributions continue to pave the way for future advancements in biotechnology.